These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8988729

  • 21. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
    D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1997 Sep 01; 39(2):335-40. PubMed ID: 9308936
    [Abstract] [Full Text] [Related]

  • 22. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy.
    Green GA, Hanlon AL, Al-Saleem T, Hanks GE.
    Cancer; 1998 Sep 01; 83(5):971-6. PubMed ID: 9731902
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.
    Cancer; 2003 Apr 15; 97(8):1884-93. PubMed ID: 12673714
    [Abstract] [Full Text] [Related]

  • 24. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E.
    Cancer J Sci Am; 1997 Apr 15; 3(2):78-87. PubMed ID: 9099457
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic postprostatectomy irradiation.
    Youssef E, Forman JD, Tekyi-Mensah S, Bolton S, Hart K.
    Clin Prostate Cancer; 2002 Jun 15; 1(1):31-6. PubMed ID: 15046710
    [Abstract] [Full Text] [Related]

  • 26. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.
    Lee WR, Hanks GE, Schultheiss TE, Corn BW, Hunt MA.
    J Clin Oncol; 1995 Feb 15; 13(2):464-9. PubMed ID: 7531222
    [Abstract] [Full Text] [Related]

  • 27. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation.
    Freedman GM, Hanlon AL, Lee WR, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):243-50. PubMed ID: 8635929
    [Abstract] [Full Text] [Related]

  • 28. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
    Valicenti RK, Chervoneva I, Gomella LG.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1093-7. PubMed ID: 15001249
    [Abstract] [Full Text] [Related]

  • 29. Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml.
    Herold D, Hanks G, Movsas B, Hanlon A.
    Radiat Oncol Investig; 1997 Mar 15; 5(1):15-9. PubMed ID: 9303052
    [Abstract] [Full Text] [Related]

  • 30. Patterns and fate of PSA bouncing following 3D-CRT.
    Hanlon AL, Pinover WH, Horwitz EM, Hanks GE.
    Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):845-9. PubMed ID: 11429210
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Jul 15; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 33. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer.
    Cheng GC, Chen MH, Whittington R, Malkowicz SB, Schnall MD, Tomaszewski JE, D'Amico AV.
    Int J Radiat Oncol Biol Phys; 2003 Jan 01; 55(1):64-70. PubMed ID: 12504037
    [Abstract] [Full Text] [Related]

  • 34. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
    D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN.
    Cancer; 1998 Jan 15; 82(2):334-41. PubMed ID: 9445191
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Perineural invasion in prostatic carcinoma treated with radical prostatectomy: the role of TR systematic biopsy.
    Passavanti G, Pizzuti V, Costantini FM, Nucciotti R, Stumpo M, Paolini R.
    Arch Ital Urol Androl; 2007 Mar 15; 79(1):23-5. PubMed ID: 17484400
    [Abstract] [Full Text] [Related]

  • 37. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.